2013 HCV Duke-West Virginia Telemedicine Live Webinar

September 19, 2013

This course is designed to address access to adequate treatment of patients chronically infected with hepatitis C. Access to the appropriate hepatology expertise to administer complex treatment regimens is key factor in treating these patients.

Learning Objectives

At the completion of the course the learner will be able to: 

  • Describe the rationale behind the current screening recommendations for HCV
  • Identify the predictors of HCV treatment response with current therapies
  • Manage the adverse events of HCV treatment appropriately
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit(s)™
  • 1.25 Attendance
Registration Opens: 
08/30/2013
Registration Expires: 
09/13/2015
Activity Starts: 
09/19/2013 - 6:00pm EDT
Activity Ends: 
09/19/2013 - 7:15pm EDT
Add to calendar: 
Online Activity (Webinar)
https://dukemed.webex.com/
United States

Activity Medical Director

Andrew Muir, MD, MHS
Associate Professor of Medicine
Duke Clinical Research Institute

Available Credit

  • 1.25 AMA PRA Category 1 Credit(s)™
  • 1.25 Attendance
Please login or register to take this course.

Required Hardware/software

To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php.